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ABSTRACT Apolipoprotein B (apoB) is the major protein component of large lipoprotein particles that transport lipids and
cholesterol. We have developed a detailed model of the ﬁrst 1000 residues of apoB using standard sequence alignment
programs (ClustalW and MACAW) and the MODELLER6 package for three-dimensional homology modeling. The validity of the
apoB model was supported by conservation of disulﬁde bonds, location of all proline residues in turns and loops, and
conservation of the hydrophobic faces of the two C-terminal amphipathic b-sheets, bA (residues 600–763) and bB (residues
780–1000). This model suggests a lipid-pocket mechanism for initiation of lipoprotein particle assembly. In a previous model we
suggested that microsomal triglyceride transfer protein might play a structural role in completion of the lipid pocket. We no
longer think this likely, but instead propose a hairpin-bridge mechanism for lipid pocket completion. Salt-bridges between four
tandem charged residues (717–720) in the turn of the hairpin-bridge and four tandem complementary residues (997–1000) at
the C-terminus of the model lock the bridge in the closed position, enabling the deposition of an asymmetric bilayer within the
lipid pocket.
INTRODUCTION
Apolipoproteins are responsible for the transport of lipids and
cholesterol. Apolipoprotein B (apoB) is a non-exchangeable
lipoprotein and exists in two forms in humans, apoB-100 and
apoB-48. ApoB-100 is the full-length protein, consisting of
4536 amino acid residues. ApoB-48 is the truncated form of
apoB-100 (consisting of amino acid residues 1–2152) and is
produced by the introduction of a premature stop codon in the
mRNA sequence by alternative mRNA splicing by the
APOBEC-1 complex (Chen et al., 1987; Greeve et al., 1991).
ApoB-48 is synthesized in the intestine and is essential for the
formation and secretion of chylomicrons. ApoB-100 is syn-
thesized in the liver and is an essential structural component of
very low density lipoprotein, intermediate-density lipopro-
tein, and low-density lipoprotein. ApoB-100 also serves as
a ligand for receptor-mediated uptake of low-density lipo-
protein (LDL) by a variety of cells (Law and Scott, 1990;
Schumaker et al., 1994; Welty et al., 1995). Deﬁciency in
apoB secretion is accompanied by lack of very low density
lipoprotein and chylomicron production, leading to malab-
sorption of fats and fat-soluble vitamins (Linton et al., 1993;
Sharp et al., 1993; Shoulders et al., 1993). High plasma levels
of LDL-cholesterol and apoB are risk factors for atheroscle-
rosis, a leading cause of death in western countries (Snider-
man et al., 1980; Tyroler, 1987).
Because of its high insolubility in an aqueous environment,
apoB is irreversibly associated with the lipoprotein particle
and is never found free in the plasma. This insolubility has
made determining the structure of apoB difﬁcult. Experimen-
tal evidence and theoretical predictions have offered insights
into the structure of apoB and the apoB lipoprotein particles.
Early work using calorimetry and x-ray diffraction (Atkinson
et al., 1977; Deckelbaum et al., 1977, 1975; Muller et al.,
1978), and more recently cryo-electron microscopy (Chatter-
ton et al., 1995a,b, 1991; Gantz et al., 2000; Spin and
Atkinson, 1995; van Antwerpen et al., 1997, 1999), indicated
that apoB is located on the surface of a spheroidal lipoprotein
particle.
Computer analysis with the program LOCATE led to the
currently accepted pentapartite model (NH2-ba1-b1-a2-b2-
a3-COOH) for apoB-100 in which domains rich in amphi-
pathic b-sheets alternate with those rich in amphipathic
a-helices (Segrest et al., 1994). LOCATE examines the
protein sequence to predict the location of amphipathic
a-helices if patterns of hydrophilic and hydrophobic residues
repeat with a period of ;3.6 residues; and amphipathic
b-strands for patterns of alternating hydrophilic and hydro-
phobic residues. These results were valuable in getting an
overall idea of the topology and domains of apoB-100, but
did not provide data that could produce a detailed structural
model for apoB.
Sequence analyses and intron/exon boundary identiﬁcation
of apoB have indicated that the N-terminal ba1-domain is
homologous to the lipovitellins (Baker, 1988; Shoulders et al.,
1994). Lipovitellins are major lipid transport proteins of egg
laying species, transporting lipids from the liver to the
oocytes. The crystal structure of silver lamprey lipovitellin
has been determined at 2.8 A˚ resolution and reveals ab-barrel
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structure (bC-region) sitting on top of a triangular-shaped
cavity (Raag et al., 1988; Sharrock et al., 1992). The cavity is
bounded by three b-sheets (bA, bB, bD) that were proposed
to accommodate lipids within the cavity or lipid pocket; two
partially resolved lipids were associated with the b-barrel in
the crystal structure (Raag et al., 1988; Sharrock et al., 1992).
ThebA- andbB-sheets form two sides of the pocket, whereas
the bD-sheet forms the base, leaving two triangular-shaped
openings at either end of the pocket. An 11-stranded, partially
closed b-barrel (bC) is found at the N-terminal end. Sur-
rounding the smallest open end of the triangular bA/bB/bD
cavity is a belt formed by17 antiparallel a-helices that are
stacked in a double layer.
ApoB sequence homology to lipovitellin allowed a struc-
tural model for the N-terminal 587 residues of apoB to be
generated using the crystal structure of silver lamprey
lipovitellin (Mann et al., 1999). This model offered valuable
insight into the bC-domain and the a-helical domain
(1–587) of apoB, but since it did not extend into the lipid-
binding pocket of lipovitellin (587–1529), it did not offer
insights into the mechanism for initial assembly of the lipid
components of apoB-containing lipoprotein particles.
Further sequence analysis has suggested that the homology
of lipovitellin and apoB extends beyond the ﬁrst 587 amino
acids, to include the ﬁrst 1000 amino acid residues of apoB
(Segrest et al., 1999), a region that includes the bA- and bB-
domains of lipovitellin. Because this region is homologous to
the proposed lipid binding cavity in lipovitellin, it was
proposed that this region might be a lipid-binding pocket for
apoB (Segrest et al., 1999). Since the homology of apoB did
not extend to the bD-sheet in lipovitellin, it was suggested
on the basis of the presence of a pronounced cluster of
amphipathic b-strands identiﬁed by LOCATE that micro-
somal triglyceride transfer protein (MTP) might function as
the bD-domain, closing the base of the lipid pocket (Segrest
et al., 2001). MTP has been proposed to act as a lipid transfer
protein (Du et al., 1996; Wetterau et al., 1997) and is appar-
ently required for the secretion of apoB-containing particles.
Further, MTP may have more than one function (Herscovitz
et al., 1991).
In this article we report further studies on the homology of
the ﬁrst 1000 amino acids of apoB to the lipovitellins using
local sequence homology search methods to expand the
sequence identity/similarity between apoB and lipovitellin.
These results have located conserved blocks of sequences
beyond the ﬁrst 600 residues in apoB. Sequence comparison
using the program LOCATE has identiﬁed conserved
amphipathic b-strands in human apoB and mouse apoB.
From these analyses we have created a structural model of the
ﬁrst 1000 residues of apoB (the ba1-domain). This model
provides further insights into the proposed lipid-binding
pocket of apoB, identiﬁes the domains that are responsible for
lipid association, and suggests the possible mechanism by
which apoB adjusts its structure to initiate particle assembly
and accommodate lipid particle expansion.
MATERIALS AND METHODS
Sequence and model accession numbers
Human apoB (accession number LPHUB), mouse apoB (XP_137955),
lamprey vitellogenin (AAA49327), chicken vitellogenin (P87498), sturgeon
vitellogenin (Q90243), frog vitellogenin (P18709), tilapia vitellogenin
(T31095), trout vitellogenin (JC4956), and killiﬁsh vitellogenin (Q90508)
sequences are available at the NCBI database. Rabbit and lemur apoB
sequences were obtained from the genomic DNA sequences deposited in the
Berkeley PGA, an NHLBI-supported Program for Genomics Applications.
The accession number for lamprey lipovitellin is 1LLV and can be found in
the Protein DataBank.
Database searches and alignments
The ﬁrst 1000 residues of apoB were used to identify homologous proteins
using the web-based BLASTp program from the National Centre for
Biotechnology (Altschul et al., 1990). The default settings were used for the
BLASTp search. The most signiﬁcant matches to human apoB belonged to
rat, opossum, and pig apoB proteins, along with a multitude of vitellogenin
proteins from a wide range of species including silver lamprey lipovitellin.
The alignment program ClustalW (Thompson et al., 1994) was used to
align silver lamprey lipovitellin (residues 1–1074) and apoB (residues
1–1000) giving a global alignment for the two sequences. The program
MACAW(Schuler et al., 1991)was used to identify local sequence homology
in the ﬁrst 1000 amino acid sequences of mouse and human apoB and the ﬁrst
1100 amino acid sequences of lamprey, frog, and chicken lipovitellins. The
program LOCATE (Segrest et al., 1994) was then used to identify potential
amphipathicb-strands in the ﬁrst 1000 amino acids of bothmouse and human
apoB. The ﬁnal alignment was a merging of the ClustalW (1–620) and
MACAW alignments (621–1000), with the LOCATE analysis being used as
a guide in aligning regions 600–1000 in apoB.
Modeling
The ﬁnal alignment was used to generate the structural model of the ﬁrst
1000 amino acids of human apoB using the program MODELLER6 (Sali
and Blundell, 1993). To eliminate serious steric problems, and to optimize
bond lengths and angles, the model was subject to 250 steps of steepest
descent energy minimization using the DISCOVER program package from
INSIGHT2 (Accelerys, San Diego, CA). Graphical representation of the
model was created by RIBBONS (Carson, 1991). Distance measurements
were done using both INSIGHT2 and RASMOL (Sayle and Milner-White,
1995). The generation of the helix-turn-helix motif model was done using
MODELLER6 and INSIGHT2, and was used to orient the helix-turn-helix
ﬂap into the model and correct steric problems.
Truncation and lipid content analysis
Expression plasmids encoding C-terminally truncated forms of apoB-100,
i.e., apoB-20.5, apoB-22.0, and apoB-26.5 (1–931, 1–1000, and 1–1200,
respectively, of the mature protein lacking the signal peptide) were con-
structed as previously described in detail (Dashti et al., 2002). Clonal stable
transformants of rat hepatoma McA-RH7777 cells expressing above
truncated forms of apoB-100 were generated as previously described (Dashti
et al., 2002).
Cells were incubated for 24 h in serum-free Dulbecco’s modiﬁed Eagle’s
medium (DMEM) containing 0.4 mM of unlabeled or [14C]-labeled oleic
acid bound to 0.75% bovine serum albumin (BSA) as previously described
(Dashti et al., 2002). The unlabeled conditioned medium was concentrated
10-fold and subjected to density gradient ultracentrifugation as previously
described. Forty fractions of 1.0 ml each were collected from the bottom of
the centrifuge tube, their densities were measured, and they were analyzed
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by 4–20% nondenaturing gradient gel electrophoresis and Western blotting
as previously described (Dashti et al., 2002). In metabolically labeled cells,
conditioned medium was concentrated 10-fold and applied to 4–20%
nondenaturing gradient gel electrophoresis. The gels were dried and
subjected to autoradiography and analyzed by computer-assisted densitom-
etry using Labsystem (Helsinki, Finland).
RESULTS
ApoB homology over the ﬁrst 1000 residues
The complete sequences of human apoB-100 and silver
lamprey lipovitellin were aligned using ClustalW (alignment
not shown). This alignment indicated that the homology
between these two proteins was located in the ﬁrst 1000
residues of apoB. The ﬁrst 1000 residues of human apoBwere
entered into the homology search program BLASTp to
identify homologous sequences. The sequence for the ﬁrst
1000 residues of apoB was compared against all other
sequences in the database and themost statistically signiﬁcant
hits were determined. A summary of the results is displayed in
Table 1 and shows that the most signiﬁcant hits are to those of
apoB from opossum, pig, and rat. Also included in this list are
the vitellogenin proteins from amultitude of different species,
including silver lamprey lipovitellin, whose crystal structure
with bound lipids has been recently determined (Raag et al.,
1988; Sharrock et al., 1992; Thompson and Banaszak, 2002).
Generation of the alignment
A homology search was done using BLASTp (Table 1), the
results of which indicated that the ﬁrst 1000 residues of
human apoB are homologous to the ﬁrst 1075 amino acids of
lamprey lipovitellin. Two alignment programs, ClustalW
and MACAW, were employed in order to create the best
alignment possible. ClustalW (default settings) provides an
alignment over entire sequences of apoB and lipovitellin.
The alignment was highly conserved over the ﬁrst 620 res-
idues of apoB, but was not as conserved beyond that point.
This is where the MACAW analysis was pivotal. MACAW
determines blocks of locally conserved regions between se-
quences with homology gaps.
Both alignments (MACAW and ClustalW) were identical
over the ﬁrst 620 amino acids of apoB (Fig. 1 A). The
MACAW alignment identiﬁed a set of 10 local domains with
signiﬁcant sequence similarity between human apoB and
lipovitellin (data not shown); ﬁve of these homologous
domains were located between residues 620 and 1000 (Fig. 1
B). To optimize the alignment and examine the functional
properties of the sequence between residues 600 and 1000
in the human apoB sequence, an analysis was done to
predict amphipathic b-stranded domains using LOCATE.
The ﬁrst 1000 residues of mouse and human apoB were
analyzed by LOCATE (data not shown) and 17 amphipathic
b-strands possessing signiﬁcant lipid afﬁnity were deter-
mined (Fig. 1 C).
To optimize the alignment between residues 621 and 1000,
the homologous domains determined byMACAWwere held
ﬁxed. By orienting the hydrophobic faces of the amphipathic
b-strands toward the lipid pocket interior, the LOCATE
analysis for amphipathicb-strandswas used to optimize those
regions between the conserved domains. Between residues
621 and 1000 we detected 18.6% identity and 40.4% sim-
ilarity to the lamprey lipovitellin sequence; between residues
1 and 1000 (Fig. 2) apoB had 20.1% identity and 39.6%
similarity to lipovitellin (residues 1–1074). These numbers
for identity and similarity are similar to those achieved by
Mann and co-workers for their apoB model that contained
only residues 1–587 (Mann et al., 1999). Although these
numbers are low, they should provide a useful low-resolution
model.
The apoB-1000 (ba1-domain) model
Using the alignment generated and the crystal structure of
silver lamprey lipovitellin, a model of the ﬁrst 1000 residues
of apoB was created using the modeling program MOD-
ELLER6. The model was optimized with 250 steps of energy
minimization to correct any unfavorable angles, bonds, and
nonbonded contacts.
The overall topology of the model (Fig. 3, A and B) shows
three unique structural domains in the ﬁrst 1000 residues
(b-barrel, a-helical bundle, and two b-sheets). The confor-
mation of residues 1–587 appears to be similar to the
homology model previously generated (Mann et al., 1999).
The ﬁrst 267 residues make up a 10-stranded b-barrel that is
not completely enclosed. Inside this partially closed barrel is
TABLE 1 HOMOLOGOUS PROTEINS
Accession# Animal Protein E-value
AAH38263 Mouse ApolipoproteinB e-0
A27001 Rat ApolipoproteinB e-0
BAA86052 Opossum ApolipoproteinB e-164
JT0382 Pig ApolipoproteinB 2e-95
AAG17936 Chrex Vitellogenin 2e-34
BAB69831 Giant prawn Vitellogenin 1e-26
BAB01568 Marsupenaeus Vitellogenin 2e-23
AAL12620 Penaeus Vitellin 3e-21
P18709 African frog Vitellogenin A2 4e-16
AAD23878 Fathead minnow Vitellogenin 2e-14
Q90243 White sturgeon Vitellogenin 3e-14
Q91062 Silver lamprey Vitellogenin 2e-12
AAL01527 Larus Vitellogenin 2e-12
NP_739573 Zebra ﬁsh Vitellogenin 4e-12
AAL07472 Carp Vitellogenin 1e-11
P02845 Chicken Vitellogenin 1e-10
AAK15157 Haddock Vitellogenin 2e-10
T31095 Oreochromis Vitellogenin 3e-9
JC4956 Rainbow trout Vitellogenin 3e-8
The ﬁrst 1000 residues of human Apolipoprotein B-100 were entered into
the homology search program BLASTp (http://www.ncbi.nlm.nih.gov/
blast/) and the most signiﬁcant homologous proteins were listed. The
default settings were used for the web-based search. Italicized names are
given (Genus) when the common names were not provided in the database.
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an amphipathic a-helix. There is a large undeﬁned loop
(residues 268–300) that connects the b-barrel to a series of 17
a-helices.
The a-helical domain extends from residues 300–600 and
is arranged in a double-layered antiparallel picket fence
arrangement on the outside faces of the bA- and bB-sheets.
This domain surrounds most of the bA-sheets (residues 600–
763) and part of the bB-sheet (residues 780–1000), holding
them in place. The bA- and bB-sheets are arranged like two
sides of a three-sided pyramid, with a large opening at the
base (Fig. 3 A) and a smaller opening at the apex where the
a-helical domain is located (Fig. 3 B). Without the third side
that is provided in lipovitellin by the bD-sheet, this ar-
rangement of sheets creates a large asymmetric V-shaped hy-
drophobic cavity in the structure. There is a small loop-helix
at the apex of the two-sided pyramid (residues 764–779)
that connects the two b-sheets. There is a large undeﬁned
loop joining two adjacent strands in the bA-sheet (residues
666–746) that is not homologous to any sequence in
lipovitellin or any other sequence in the Genbank database
(data not shown). Since no structures were homologous for
the modeling of this loop, it was not included in Fig. 3.
Analysis of the apoB:1000 model
The program PROCHECK (Laskowski et al., 1993) was used
to check the geometry and steric contacts of the model and it
showed that the homology model was reasonable with 97.9%
of the residues in the allowed regions of the Ramachandran
plot (data not shown). The vast majority of those residues
outside the allowed regions were located in loops, not in
secondary structures.
Disulﬁde bonds
Of the eight disulﬁde bonds determined in apoB, seven of
them are located in the ﬁrst 1000 residues (Yang et al., 1990).
Analysis of the model indicates that all of the seven disulﬁde
bonds are correctly paired and within 6 A˚ of one another.
The model was created without manipulation or intervention
on our part, so this is very strong support for the model. The
FIGURE 1 Alignment and analysis of apoB-22.5.
(A) Sequence alignment for the ﬁrst 620 amino acids of
human apoB and the homologous residues in lip-
ovitellin. (B) The red boxes represent local sequence
homology between apoB and lipovitellin that were
recognized using the alignment program MACAW.
(C) The yellow boxes are conserved regions in mouse
and human apoB sequence that the program LOCATE
identiﬁed as potential amphipathic b-strands.
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FIGURE 2 Alignment over the ﬁrst 1000 residues of apoB. The complete alignment was used to make the apoB1000 model. The ﬁrst 620 residues of the
alignment were taken from Fig. 1 A. The alignment from 621–1000 was done using the results from the MACAW and LOCATE analyses (Fig. 1, B and C).
The text highlighted in red represents residues not resolved in the lipovitellin crystal structure.
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results indicate that the cysteines are in close enough
proximity to the correct partners so that a disulﬁde bond
could form. What makes this signiﬁcant is that only two
disulﬁde bonds in the model of apoB:1000 are homologous
(based on sequence analysis) to those found in the
lipovitellins (Table 2). The remaining ﬁve disulﬁde bonds
did not have homologous matches in the lipovitellins, but the
location of the cysteines in the model allowed them to be in
the correct proximity of their corresponding partners to form
disulﬁde bonds (Fig. 4). In particular, the disulﬁde bond
Cys939dCys949 is located near the end of the sequence and
links adjacent b-strands in the bB-sheet. In sum, these results
are a strong indication of the validity of our apoB:1000
model.
Prolines
The sequence alignment is critical for the correctness of the
homologymodel, since themodel is based on alignment to the
crystal structure. The placements of the proline residues are
highly conserved in apoB for human, mouse, rabbit, and
lemur (data not shown). In the human apoB:1000 sequence,
42 of 51 prolines are absolutely conserved between these four
apoB sequences.Only two prolines in the human sequence are
unique, with no homologous matches, whereas the remaining
seven prolines are conserved in at least one of the other apoBs.
Comparisons of the apoBs to the lipovitellins show that,
through residues 1–600, only a few prolines are conserved. A
FIGURE 3 ApoB-1000. (A) RIBBONS diagram of the apoB1000 model
looking from the large opening of the b-sheets toward the small opening. (B)
RIBBONS diagram of the apoB1000 model looking from the small opening
of the b-sheets (180 rotation from Fig. 4 A). Residues 670–745 are not
shown, but the asterisk symbol (*) in A (left diagram) indicates where the
loop would be inserted.
TABLE 2 HOMOLOGY TO DISULFIDE BONDS
Disulﬁde
pair Position
Homologous
in ApoBs
Homologous in
lipovitellins
1 12 M, L
2 51 M, R, L S, F
1 61 M, R, L
2 70 M, R, L
3 159 M, R, L L, C, S, F, T, Tr, K
3 185 M, R, L L, C, S, F, T, Tr, K
4 218 M, R, L
4 234 M, R, L
5 358 M, R, L
5 363 M, R, L F
6 451 M, R, L
6 486 M, R, L
7 939 M, R, L L, C, S, F, Tr, K
7 949 M, R, L L, C, S, F, Tr, K
M, Mouse apoB; L, lamprey lipovitellin; R, Rabbit apoB; C, Chicken
lipovitellin; L, Lemur apoB; S, Sturgeon lipovitellin; F, Frog lipovitellin;
T, Talipia lipovitellin; Tr, Trout lipovitellin; and K, Killiﬁsh lipovitellin.
Comparison of Cys positions of human apoB to apoBs and lipovitellins. The
disulﬁde pair number is a list of Cys pairs in the disulﬁde. The position
reﬂects the residue number in human apoB and the remaining two columns
lists homologous Cys in apoBs and/or lipovitellins.
FIGURE 4 Disulﬁdes in ApoB-1000. Stereo view of ApoB-1000 from the
small opening side. Cysteines are highlighted by spaceﬁll and the sulfur is
colored yellow: (1) 12Cys:61Cys; (2) 51Cys:70Cys; (3) 159Cys:185Cys; (4)
218Cys:234Cys; (5) 358Cys:363Cys; (6) 451Cys:486Cys; and (7)
939Cys:949Cys.
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higher degree of conservation of proline positioning is noted
in the b-sheet regions of the model (residues 619–1000). This
is highlighted in the bB-sheet of apoB (Fig. 5). In the ﬁrst 780
residues of the model (excusive of the bB-sheet), the prolines
are located in the expected positions: at loops and at the
beginning or end of strands and helices, and occasionally
within helices, where they can adopt a conformation that
bends the helix yet still allows the helix to continue.
In thebB-sheet region of themodel, 7 out of 12 prolines are
conserved in mouse, human, rabbit, and lemur apoB. One out
of the 12 is conserved in the apoBs and one lipovitellin and
one proline was conserved in all four apoBs and three of the
lipovitellins (Fig. 5). Only one proline is unique to human
apoB and it is located at the apex of a short turn in the model.
Most of the prolines in the bB-sheet are located in loops or at
the beginning or ending of strands of helices, except one
highly conserved proline in the middle of a b-strand (Pro850).
It is possible to have a proline in a b-strand because the ex-
pected f,c-angles of prolines do overlap in a small region of
expected b-structures (Richardson and Richardson, 1990).
Prolines are sometimes found in b-sheets, located at the
beginning/ending of strands or at the edge of a sheet.
The residue Pro850 is not conserved in the lipovitellin
crystal structure, but homologous matches were found in
mouse, rabbit, and lemur apoB and frog, tilapia, killiﬁsh,
trout, and sturgeon lipovitellin.We believe that the placement
of the prolines to be correct, because seven of these (P783,
P850, P900, P902, P905, P944, and P980) form a row that
runs perpendicular to the direction of the strands in the bB-
sheet. A portion of this row corresponds to the position of the
pronounced fold in the bB-sheet in lamprey lipovitellin; four
of the seven prolines are located in this fold in human apoB,
suggesting that the bB-sheet in apoB may have a fold across
most of its width. The high degree of conservation of the
prolines in mammalian apoBs (human, mouse, lemur, and
rabbit) in the bB-sheet and their conserved positions in the
lipovitellins further support the alignment used to create the
model.
Conservation of b-sheet hydrophobicity
The surface of the bA-sheet facing into the proposed lipid
pocket is almost uniformly hydrophobic (Fig. 6 A). The only
charged residues found in this sheet are located at the edges of
the pocket and are presumably associated with the surround-
ing solvent, not the hydrophobic interior of the lipid pocket.
The interior surface of the bB-sheet is also quite hydrophobic
(Fig. 6 B), but contains substantial differences from the
comparable face of the bA. Whereas the bA has only a few
charges at the base of the sheet, bB has charges that surround
three sides of the sheet, including a high density of positive
charges at its base (the end opposite the a-helical domain).
As already noted, the bB-sheet is also unique in that there
is a central bulge caused by a row of prolines (Fig. 5) that
extends perpendicular to the direction of the individual
b-strands of the sheet. This bulge creates a small opening in
the sheet that contains a Lysine and Aspartic acid at its apex,
residues that close most of the opening.
The molecular model for the ba1-domain of apoB shown
in Fig. 3 is therefore almost certainly correct in its general
features. The strongly amphipathic b-sheet polarity of the
bA- and bB-domains from lipovitellin has been preserved in
apoB. These sheets are held in place by their association with
the interior portion of the double-layered a-helical bundles.
Small regions of hydrophobic and hydrophilic patches on
both the bA- and bB-sheets (exterior facing the helices) and
the helical bundle match up to allow sheet-helix association.
This is additional evidence for the correctness of the model.
DISCUSSION
We have used detailed sequence analysis and the crystal
structure of silver lamprey lipovitellin to model residues
1–1000 of human apoB. Mann and co-workers used a global
sequence alignment (ClustalW), and they modeled the ﬁrst
587 residues of apoB (Mann et al., 1999). This allowed them
to do a detailed analysis on the MTP:apoB interaction, but
FIGURE 5 Proline punctuation and conservation in the bB-sheet.
Prolines are represented in the spaceﬁlling mode and colored based on
conservation. Homology based on MACAW alignments among human
apoB, mouse apoB, lemur apoB, rabbit apoB, lamprey lipovitellin, chicken
lipovitellin, frog lipovitellin, trout lipovitellin, talipia lipovitellin, killiﬁsh
lipovitellin, and sturgeon lipovitellin.
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the model did not offer insight into the lipid-binding domain
of apoB. We were able to produce an alignment over the ﬁrst
1000 residues that had similarity and identity alignment
scores similar to that of the Mann model.
Both models also contain the critical D524-R531-E557
buried salt-bridge in identical positions. This salt-bridge was
identiﬁed as homologous in MTP and lipovitellins and
proposed as an important structural feature for stabilizing the
protein structure in the a-helical region (Mann et al., 1999).
Mutations at these key residues cause the proteins to lose
solubility and unfold (Mann et al., 1999).
Recent proteoglycan-binding experiments are also con-
sistent with our model. It has been proposed that residues
84–94 of apoB are the principal proteoglycan binding sites in
chylomicrons and LDL (Flood et al., 2002; Goldberg et al.,
1998). This region is located at an exposed loop that sits at
the base of the bC-domain (b-barrel) in our model. There are
three lysines in this location that could potentially bind to
proteoglycan.
The model shown in Fig. 3 is incomplete, since the third
side of the pyramidal hydrophobic cavity required to create an
effective lipid pocket like that possessed by lipovitellin is
missing. It was for this reason that we originally suggested
that MTP might create the third side (Segrest et al., 1999).
However, further analysis of the apoB:1000 model suggests
an alternate possibility for the structural nature of the third
side to the pocket. A tandem series of four charged residues
(Arg997, Glu998, Asp999, and Arg1000) is located at the
C-terminal end of themodel and forms a portion of the base of
the bB-sheet. On further analysis of the apoB:1000 sequence,
a complementary tandem series of four charges (Glu720,
His719, Lys718, Asp717) was found in the unmodeled loop
region (670–745) located in the middle of the bA-sheet.
LOCATE analysis of residues 670–745 showed the presence
of two well-deﬁned amphipathic helices AH702–716 and
AH721–738, predicted to be strongly lipid-associating. Signif-
icantly, the complementary tandem charges are located
precisely between the two putative amphipathic helices,
suggesting a helix-turn-helix motif.
We have built a helix-turn-helixmodel of residues 700–744
using the LOCATE analysis as a guide. The helix-turn-helix
model was incorporated into the apoB model to create
a partially closed lipid pocket (Fig. 7 A). This hairpin-bridge
spans the third side of the pyramidal lipid pocket allowing the
charged residues in the turn region to form complementary
salt-bridges with the charged residues in the C-terminal
portion of the bB-sheet. The hydrophobic faces of the helices
orient toward the lipid-binding pocket (Fig. 7 B). Four
salt-bridges can be formed from this arrangement: Arg997—
Glu720, Glu998—His719, Asp999—Lys718, and Arg1000—
Asp717 (Fig. 7 C). We propose that the salt-bridges serve as
a lock to close the third side of the asymmetric pyramidal lipid
pocket by the creation of a hairpin-bridge that completes the
nascent step of lipoprotein particle assembly.
It seems probable that the lipids would form a bilayerlike
assembly in the nascent lipid pocket. This conclusion is
based upon the depth of the pocket (;40 A˚) similar to the
thickness of the hydrophobic core of a phospholipid bilayer
and the strong tendency of phospholipids to assemble as
bilayers. In such an assembly, the charged headgroups of the
phospholipids would be located at the basal and apical
openings of the lipid pocket, associating with the charges
at the edges of the b-sheets; the fatty acyl chains of the
phospholipids would be directed into the hydrophobic cavity
formed by the bA- and bB-sheets.
We have manually docked 48 POPC molecules into the
lipid pocket of the apoB:1000 model to create an asymmetric
bilayer with 14 POPC in the apical monolayer and 34 POPC
in the basal monolayer (Fig. 8). A few more POPC molecules
could be docked into the pocket if the bilayer surfaces were
allowed to curve and more sophisticated methods, such as
energy minimization and molecular dynamics, were used in
creating the model. Experimentally apoB:1000 is secreted
in the form of a lipoprotein particle, containing ;50
FIGURE 6 Hydrophobicity of the bA- and bB-sheets. Stereo diagrams of
the bA-sheet (A) and the bB-sheet (B). The faces shown are those that are
exposed to the interior of the opening between the bA- and bB-sheets.
Hydrophobic residues are colored gold, acidic residues are red, basic
residues are blue, prolines are green, and polar residues not belonging to any
of the group above are gray.
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phospholipids per particle (Manchekar et al., 2004), which is
an excellent ﬁt to our model.
We believe that the hairpin-bridge is a transient in-
termediate in lipoprotein assembly with two distinct forms:
a locked hairpin-bridge that closes the pocket to allow the
formation of a nascent lipoprotein particle with deﬁned lipid
content, and an unlocked form that allows an increase in the
particle size and decrease in the particle density through
addition of lipid.
We previously showed (Dashti et al., 2002) that the major
apoB-containing particles formed by B:931 (residues 1–931)
have a constant diameter of 110 A˚ across a wide range of
densities and amean density of 1.25 g/ml or greater; therefore,
this particle contains little lipid and is considerably denser
than traditional HDL,which has density in the range of 1.063–
1.21 g/ml (Dashti et al., 2002). The major apoB-containing
particle formed by B:1000 has a diameter that remains
constant at ;112 A˚ across a wide range of densities and
a mean density of 1.21 g/ml that is within the HDL3 density
range of 1.125–1.21 g/ml (Dashti et al., 2002). Thus over
a short stretch of 69 residues from apoB:931 to apoB:1000,
the nature of the secreted particles changes from lipid-poor to
an HDL-like particle (Fig. 9). This was conﬁrmed by
incorporation of [14C]-labeled oleic acid into the lipid fraction
of the particles, determined by autoradiography and densi-
tometry, showing a 10-fold increase in the lipid content of
apoB:1000-containing particles relative to those reconstituted
with apoB:931. Finally, the larger apoB:1200 particle has
FIGURE 7 Lipid pocket. (A) RIBBONS diagram of the apoB1000 model,
including the modeled helix-loop-helix region (700–744). (B) Ribbons
diagram of the proposed lipid pocket domain of the apoB1000 model,
including the modeled helix-loop-helix. The critical residues responsible for
the salt-bridges are represented in an all-atom detail as tubes. (C) Ribbons
diagram of a closeup of the region responsible for the lock that stabilizes the
helix-loop-helix. The critical residues are shown as tubes, and the salt-
bridges are represented as solid lines.
FIGURE 8 The lipid pocket. ApoB-22.5 is represented with b-strands
shown as yellow arrows and a-helices shown as purple tubes. POPC is
shown as spaceﬁll rendering with carbons in gray and oxygen in red. There
are 34 POPC in the large opening and 14 POPC in the small opening, for
a total of 48 POPC ﬁt into the lipid pocket of ApoB-22.5.
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a diameter that increased with decreasing density, ranging
from 118 to 127 A˚, and a mean density of 1.197 g/ml that is
within the HDL density range, clearly indicating that the
apoB:1200 particle contains additional, but varying, lipid
compared to the apoB:1000 particle.
These results suggest the followingmodel: The lipid pocket
created upon formation of B:1000 is involved co-translation-
ally in the preliminary acquisition of phospholipids and
triglycerides to form a nascent lipoprotein particle. Beyond
residue 1000 lies the b1-domain containing multiple amphi-
pathic b-strands. Translation of these structural motifs pro-
vides a mechanism for lipoprotein particle growth beyond the
nascent apoB:1000 particle. Co-translation of the amphi-
pathic b-sheets of the b1-domain beyond residue 1000 tightly
couple with accumulation of additional lipid molecules in the
pocket, inducing opening of the hairpin-bridge. To create
a stable particle, the hairpin-bridge opening would have to
occur simultaneously with addition of multiple amphipathic
b-strands to the lipoprotein particle surface to form stabilizing
amphipathic b-sheets. As the lipid pocket expands, lipids
would be added to the ﬂexible basal opening of the lipid
pocket, to create what is, in effect, an expanding lipid droplet.
Residues 764–779 would serve as the pivot point for the
pocket opening and separation of thebA- andbB-sheets at the
basal end (Fig. 10). The hairpin-bridge would unlock and
open the base of the pocket, and the amphipathic helices of the
helix-turn-helix would associate with the growing particle.
Ultimately this would cause the V-shaped pocket between
bA- and bB-sheets to open. The open conformation would
easily associate with the surface of a spheroidal particle that is
much larger in size than that of the B:1000 domain of the
protein itself. We suggest that this would be the conformation
of apoB bound to LDL, intermediate-density lipoprotein, and
chylomicrons.
Our hairpin-bridge lipid pocket model suggests that
apoB:1000 can assemble lipid, presumably delivered by
MTP acting as a shuttle, to form a nascent lipoprotein particle
without requiring MTP to also serve as an integral structural
element of the lipid pocket. It has been shown (Manchekar
et al. 2004) that apoB:1000 forms stable particles without the
1:1 ratio of apoB to MTP required if MTP were serving as
a structural member of the lipid pocket. These results together
show that, compatible with our hairpin-bridge pocket closure
mechanism, MTP is not required to function as a structural
element necessary for assembly of a lipoprotein particle.
Spin and Atkinson reported images of LDL in vitreous ice
using electron cryomicroscopy at;30 A˚ resolution (Spin and
FIGURE 9 Density and lipid content of truncated apoB-containing
particles. McA-RH7777 cells were incubated for 24 h in serum-free
DMEM containing 0.4 mM of unlabeled or [14C]-labeled oleic acid bound to
0.75% BSA. Unlabeled conditioned medium was analyzed for the peak
density and [14C]-labeled conditioned medium was analyzed for the
radioactive lipid content of truncated apoB-containing particles, as described
in Materials and Methods. Solid circles represent the densities of the major
particles produced by B-20.5, B-22.5, and B-26.5. The solid triangles
represent the [14C]-labeled lipid content of these particles determined by
autoradiography and densitometry.
FIGURE 10 Open form of the pocket. Cartoon representation of apoB-
100 on the LDL particle. The ﬁrst 1000 residues are shown in detail (top of
the particle), whereas the remaining residues are represented as a cartoon
rendering based on the proposed pentapartite model for apoB-100. Blue
boxes represent amphipathic b-strands and red cylinders represent
amphipathic helices. PRD2 and PRD3 show the location of the proline-
rich domains in the model.
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Atkinson, 1995). In their study, LDL appeared to be
a quasispherical particle, ;220–240 A˚ in diameter, with
a region of low density surrounded by a ring of high density
(in projection) believed to represent apoB-100. Some images
were egg-shaped and contained a pointed end; the pointed end
had the approximate dimensions of theb-barrel in Fig. 10 and
subsequently has been shown to represent the N-terminal
globular region (the ba1-domain) of apoB (D. Atkinson,
personal communication).
One difﬁculty for making a model of apoB is the
complexity and expandability of the protein. ApoB is a very
dynamic protein that undergoes expansion and contraction as
the lipid particle changes sizes, and thiswill inherently change
the overall structure and secondary structure of the protein.
Certain regions of the model lack secondary structure where
analysis of the sequence suggests that secondary structure
might be present. A region of particular importance is the
sequence 670–701N-terminal to themodeled helix-turn-helix
(700–744). Since the sequence homology is very low for this
region so we decided not to include it in the model. LOCATE
analysis of this region (670–699) showed the presence of one
signiﬁcant amphipathic a-helix (672–680). We therefore
believe that the sequence 670–699 serves, in some as yet un-
deﬁned conformation, to close the gap present at the base of
the triangular pocket formed by the hairpin-bridge with bA
and bB.
Yet another area where the model might not reﬂect the
structure is at the C-terminus of the apoBmodel (986–995). A
unique characteristic of this region is alternating hydrophobic
and hydrophilic residues (QYSVSATYEL), suggesting that
this region is an amphipathic b-strand. It is also likely that
region 895–900 is a strand, and that the two strands are
hydrogen-bonded together to form a small sheet (model not
shown). Changing these resides to the more deﬁned
secondary structure of a b-sheet would close the second gap
present in themodel at the base of the triangular pocket, which
would cover the remaining exposed lipids.
The model suggests an answer to the question of how
triglycerides and cholesterol esters get into and out of lipid
particles. The b-barrel (bC) has a hydrophobic interior that
could bind lipids, as in the crystal structure of lipovitellin,
where a lipid has been resolved in the barrel region (Raag et al.,
1988; Sharrock et al., 1992). If there were an opening between
the b-barrel and the lipid pocket, this could provide a channel
through which triglycerides and cholesterol esters could
move. There is no such opening in our model, which re-
presents the conformation of apoB bound to only a handful
of lipids, because the bottom of the b-barrel is partially
blocked by the bA- and bB-sheets. In the mature particle,
however, the pocket formed by the bA- and bB-sheets must
be opened to ﬁt the lipid surface of the mature LDL. We have
examined the effects of widening the large opening of the
pocket, expanding the pocket by 10 A˚ (data not shown) using
the modeling package INSIGHT2. These motions are
sufﬁcient to open a channel between the b-barrel and the
lipid pocket. If this extension of our model is correct, then the
b-barrel would be the portal through which triglycerides and
cholesterol esters might move into the lipid particle as it
grows. These molecules presumably accumulate between the
leaﬂets of the bilayer in the lipid pocket initially. Although the
exact shape of the lipid particle during this accumulation is
unclear, it would not be difﬁcult to modify the lipid bilayer
in our model to accommodate triglycerides and cholesterol
esters. In the mature lipid particle, these molecules would be
transferred into or out of the interior of the particle through the
b-barrel.
The evidence from the sequence alignments (cysteine
positioning for disulﬁde bond formation, proline positioning,
and conservation of the hydrophobic faces of the amphi-
pathic bA-and bB-sheets), proteoglycan binding site experi-
ments, and the experimental data about the quantity of lipids
in the secreted apoB:1000 lipoprotein particle, all indicate
that the model is correct in its general structure. The model
suggests that there is a multitude of structural changes that
take place from the initial assembly of a nascent lipoprotein
particle to the structure of the mature lipid particle.
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